AHA omega-3 statement
This article was originally published in The Tan Sheet
Executive Summary
"Evidence from prospective secondary prevention trials suggests" eicosapentaenoic acid plus docosahexaenoic acid "significantly reduce subsequent cardiac and all-cause mortality," AHA scientific statement in Nov. 19 Circulation says. Penny Kris-Etherton, PhD, et al., suggest while a dietary approach to increase omega-3 fatty acid intake "is preferable," supplements may be considered for those who cannot consume the recommended .5 g/d to 1.8 g/d through fish alone. However, researchers note "additional studies are needed to confirm and further define the health benefits of omega-3 fatty acid supplements for both primary and secondary prevention" of coronary disease. Patients taking more than 3 g of EPA + DHA from supplements "should do so only under a physician's care," Kris-Etherton et al. add...